Sign In
New User?
Register for Mayo Medical Laboratories
MayoAccess™
Use
Manage
Contact Us
United States, Canada
- 800-533-1710
- 507-266-5700
- More options
International
- +1 507 266 5700
- More options
Quick Links
Reference Laboratory Services for
Health Care Organizations
Specimen Shipment Alert
Memorial Day, observed on Monday, May 27, is a U.S. national holiday.
To ensure that your specimen vitality and turn-around time are not affected, plan ahead and note that requirements have changed this year:
- No pickups or deliveries will be made on May 27 by either couriers or FedEx.
- Procedure change for handling Frozen specimens picked up on Saturday and shipped by FedEx: Due to stability issues (thawed specimens), we are now requesting that those who ship to Mayo on Saturday by FedEx hold their frozen samples until Tuesday’s pickup. Those who still insist samples be sent must completely fill styro with dry ice.
- FedEx items not delivered on Sunday, May 26, will not be delivered until Tuesday, May 28.
- Items scheduled for Saturday or Sunday delivery will be unaffected.
Published on May 17, 2013
Utilization Management Conference 2013
A Practical Approach for Pathology and Clinical Laboratory Test Utilization
Register Now!
Date: October 8, 2013
Location: The Loews Hotel in Atlanta, GA
Learn how a clinician, laboratorian and pathologist can work together to build an effective test utilization strategy. Join us as we discuss how the laboratory can play an essential role in directing cost-effective and appropriate testing, especially during this time of decreasing reimbursement and demand for health care practice standardization. By the end of this event, you will have a clear insight on how to begin or advance the utilization management efforts in your laboratory.
Published on May 20, 2013 Learn more...
Hot Topics
The Region 4 Stork (R4S) Collaborative Project, Part 1: Laboratory Quality Improvement of Newborn Screening
Newborn screening has been very successful in identifying newborns with classic syndromes. However, many newborns have complex metabolic profiles that are difficult to interpret, leading to false-positives and missed diagnoses. To improve detection of true-positives, the Regional Genetics Collaborative project, funded by the Health Resource and Service Administration, has created the Region 4 Collaborative Stork project, which uses Mayo-developed software for postanalytical interpretation of complex metabolic profiles.
Part 1 introduces the concept of disease ranges for improved identification of abnormal newborn screening results.
A 6-part presentation by Piero Rinaldo, MD, PhD
Published on May 15, 2013View presentation...
Mycobacteria
3 Questions to Successfully Identify Mycobacteria and Guide Treatment
Identification and treatment of mycobacteria involve difficult, multistep processes. Mistakes in the handling of either aspect may result in unsuccessful treatment and an increased likelihood of drug resistance.
Successful identification and, ultimately, treatment of mycobacteria is guided by the answers to 3 essential questions.
Published on May 13, 2013 Learn more...
Hereditary Colon Cancer
Next Generation Sequencing Panel
Hereditary colon cancer screening can help identify presymptomatic or asymptomatic individuals within a family and allow clinicians to utilize early screening and monitoring options that optimize potential for early detection.
This panel uses next generation sequencing (NGS), array comparative genomic hybridization (aCGH), and other technologies to evaluate for germline mutations in 17 genes known to be associated with an increased risk for colon cancer development.
Published on May 8, 2013 Learn more...
2013 Phlebotomy Conference
Registration Is Now Open
Phlebotomy 2013: Advancing the Profession and Practice of Phlebotomy
Dates: October 3-4, 2013
Location: The Kahler Grand Hotel in Rochester, MN
Topics include: Obtaining quality blood collections from venous lines, handling difficult sticks, trends in lead screening in children, and first-hand experiences utilizing central versus regionalized phlebotomy teams for hospital collections.
The conference balances breakout sessions geared towards specific areas of interest with large group dialogues on general topics, interactive case studies and a panel discussion.
Published on May 7, 2013 Learn more...
Hot Topics
Acute Promyelocytic Leukemia with t(15;17)(q24;q21); PML-RARA
Acute promyelocytic leukemia (APL) with t(15;17)(q24;q21); PML-RARA comprises 5% to 10% of all acute myelogenous leukemia (AML) cases. APL can often be differentiated from other types of AML based on bone marrow morphology, but the genetic aberration is diagnostic of APL regardless of blast percentage. Cytochemistry, flow cytometry, conventional cytogenetics and PML-RARA identification by RT-PCR and FISH are all important laboratory assays for the diagnosis of APL.
A presentation by Kaaren Reichard, MD
Published on May 1, 2013View presentation...





